Deutsche Bank cuts Xenon Pharmaceuticals to Hold from Buy
Deutsche Bank cut Xenon Pharmaceuticals from Buy to Hold and reduced its price target to $46.00 from $90.00, per Benzinga.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.